| Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) (NCT07445984) | Azienda Ospedaliero-Universitaria di Parma | 2021-07-28 |
| Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. (NCT04965649) | Centre Hospitalier Universitaire de Nīmes | 2021-01-01 |
| Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant (NCT03588936) | Medical College of Wisconsin | 2018-09-14 |
| Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor (NCT02842333) | Centre Hospitalier Universitaire de Besancon | 2016-05-01 |
| Umbilical Cord Blood Transplantation From Unrelated Donors (NCT03016806) | University of Rochester | 2015-06-01 |
| Nonmyeloablative Haploidentical Transplant Followed by MLN9708 (NCT02169791) | Northside Hospital, Inc. | 2014-07-15 |
| Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor (NCT01598025) | Memorial Sloan Kettering Cancer Center | 2012-05-02 |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells (NCT01624701) | Singapore General Hospital | 2012-03-01 |
| Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation (NCT01472055) | Seoul National University Hospital | 2011-10-01 |
| Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases (NCT01336712) | Northside Hospital, Inc. | 2011-04-01 |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT01800643) | Hospital Israelita Albert Einstein | 2010-03-01 |
| Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor (NCT01362985) | Genzyme, a Sanofi Company | 2009-07-01 |
| Trial of AVN-944 in Patients With Advanced Hematologic Malignancies (NCT00273936) | Vertex Pharmaceuticals Incorporated | 2006-01-01 |
| Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia (NCT00230282) | Steven E. Coutre | 2004-07-01 |
| Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes (NCT00899223) | Alliance for Clinical Trials in Oncology | 1996-05-01 |